胰岛素
内科学
内分泌学
高胰岛素血症
外围设备
胰岛素类似物
碳水化合物代谢
新陈代谢
医学
葡萄糖摄取
胰岛素振荡
肝门静脉
门静脉
胰岛素抵抗
人胰岛素
作者
Dale S. Edgerton,Melanie F. Scott,Ben Farmer,Phillip E. Williams,Peter Madsen,Thomas Kjeldsen,Christian Lehn Brand,Christian Fledelius,Erica Nishimura,Alan D. Cherrington
出处
期刊:JCI insight
[American Society for Clinical Investigation]
日期:2019-02-26
卷期号:4 (7)
被引量:61
标识
DOI:10.1172/jci.insight.126974
摘要
Peripheral hyperinsulinemia resulting from subcutaneous insulin injection is associated with metabolic defects which include abnormal glucose metabolism. The first aim of this study was to quantify the impairments in liver and muscle glucose metabolism that occur when insulin is delivered via a peripheral vein compared to when it is given through its endogenous secretory route (the hepatic portal vein) in overnight fasted conscious dogs. The second aim was to determine if peripheral delivery of a hepato-preferential insulin analog could restore the physiologic response to insulin that occurs under meal feeding conditions. This study is the first to show that hepatic glucose uptake correlates with insulin's direct effects on the liver under hyperinsulinemic-hyperglycemic conditions. In addition, glucose uptake was equally divided between the liver and muscle when insulin was infused into the portal vein, but when it was delivered into a peripheral vein the percentage of glucose taken up by muscle was 4-times greater than that going to the liver, with liver glucose uptake being less than half of normal. These defects could not be corrected by adjusting the dose of peripheral insulin. On the other hand, hepatic and non-hepatic glucose metabolism could be fully normalized by a hepato-preferential insulin analog.
科研通智能强力驱动
Strongly Powered by AbleSci AI